Jane de Lemos

400 total citations
19 papers, 253 citations indexed

About

Jane de Lemos is a scholar working on Geriatrics and Gerontology, Critical Care and Intensive Care Medicine and General Health Professions. According to data from OpenAlex, Jane de Lemos has authored 19 papers receiving a total of 253 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Geriatrics and Gerontology, 4 papers in Critical Care and Intensive Care Medicine and 4 papers in General Health Professions. Recurrent topics in Jane de Lemos's work include Pharmaceutical Practices and Patient Outcomes (7 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Intensive Care Unit Cognitive Disorders (3 papers). Jane de Lemos is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (7 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Intensive Care Unit Cognitive Disorders (3 papers). Jane de Lemos collaborates with scholars based in Canada, United States and China. Jane de Lemos's co-authors include Dean R. Chittock, Martin Tweeddale, Peter Loewen, Teresa Lee, Stephen Ho, Richard K. Simons, Richard S Slavik, Peter Wing, Sean K Gorman and David R. Bevan and has published in prestigious journals such as Critical Care Medicine, Journal of Clinical Epidemiology and Diabetes & Metabolic Syndrome Clinical Research & Reviews.

In The Last Decade

Jane de Lemos

18 papers receiving 243 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jane de Lemos Canada 9 84 73 49 48 43 19 253
Mary Beth Bobek United States 8 75 0.9× 59 0.8× 113 2.3× 18 0.4× 62 1.4× 12 376
Chris Thorpe United Kingdom 8 45 0.5× 66 0.9× 61 1.2× 28 0.6× 50 1.2× 19 242
Benjamin Hohlfelder United States 11 71 0.8× 51 0.7× 33 0.7× 26 0.5× 156 3.6× 30 362
Mahmoud Ammar United States 10 91 1.1× 40 0.5× 8 0.2× 90 1.9× 63 1.5× 31 310
Earnest Alexander United States 9 75 0.9× 50 0.7× 81 1.7× 36 0.8× 29 0.7× 29 275
Sarah Welch United States 8 76 0.9× 60 0.8× 8 0.2× 32 0.7× 17 0.4× 19 385
Allan Shustack Canada 10 190 2.3× 37 0.5× 65 1.3× 133 2.8× 99 2.3× 16 508
Codjo D. Djade Italy 10 125 1.5× 42 0.6× 206 4.2× 9 0.2× 112 2.6× 13 398
Maria C. Pruchnicki United States 13 41 0.5× 19 0.3× 148 3.0× 23 0.5× 56 1.3× 32 383
P Mello Brazil 7 166 2.0× 64 0.9× 37 0.8× 112 2.3× 64 1.5× 10 437

Countries citing papers authored by Jane de Lemos

Since Specialization
Citations

This map shows the geographic impact of Jane de Lemos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane de Lemos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane de Lemos more than expected).

Fields of papers citing papers by Jane de Lemos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane de Lemos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane de Lemos. The network helps show where Jane de Lemos may publish in the future.

Co-authorship network of co-authors of Jane de Lemos

This figure shows the co-authorship network connecting the top 25 collaborators of Jane de Lemos. A scholar is included among the top collaborators of Jane de Lemos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane de Lemos. Jane de Lemos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
3.
Kumar, Jessica, et al.. (2020). Evaluation of the Management of Acute Exacerbations of Chronic Obstructive Pulmonary Disease in Hospitalized Patients. Journal of Pharmacy Technology. 36(5). 187–195. 2 indexed citations
4.
Lemos, Mário L de, et al.. (2019). Concomitant use of capecitabine and proton pump inhibitors – Is it safe?. Journal of Oncology Pharmacy Practice. 25(7). 1705–1711. 13 indexed citations
5.
Silva, Isabel, et al.. (2018). The impact of glycemic variability on length of stay and mortality in diabetic patients admitted with community-acquired pneumonia or chronic obstructive pulmonary disease. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 13(1). 149–153. 17 indexed citations
6.
Lemos, Jane de, et al.. (2015). Evaluation of Protocol-Guided Scheduled Basal-Nutritional-Correction Insulin Over Standard Care for Vascular Surgery Patients. Canadian Journal of Diabetes. 39(3). 210–215. 3 indexed citations
7.
Taylor, Robert L., et al.. (2013). Online versus Live Delivery of Education to Pharmacists in a Large Multicentre Health Region: A Non-inferiority Assessment of Learning Outcomes. The Canadian Journal of Hospital Pharmacy. 66(4). 233–40. 9 indexed citations
8.
Loewen, Peter, et al.. (2012). Diagnostic Reasoning by Hospital Pharmacists: Assessment of Attitudes, Knowledge, and Skills. The Canadian Journal of Hospital Pharmacy. 65(4). 258–64. 5 indexed citations
9.
Lemos, Jane de, et al.. (2011). Improving the Quality of Clinical Pharmacy Services: A Process to Identify and Capture High-Value “Quality Actions”. The Canadian Journal of Hospital Pharmacy. 64(1). 42–7. 15 indexed citations
10.
Lee, Teresa, et al.. (2010). Quality and Usability of Common Drug Information Databases. The Canadian Journal of Hospital Pharmacy. 63(2). 130–7. 32 indexed citations
11.
Loewen, Peter, et al.. (2010). Pharmacists´ perceptions of the impact of care they provide. Pharmacy Practice. 8(2). 89–95. 3 indexed citations
12.
Barry, Arden R., et al.. (2010). Reasons for non‐use of proven pharmacotherapeutic interventions: systematic review and framework development. Journal of Evaluation in Clinical Practice. 18(1). 49–55. 8 indexed citations
13.
Loewen, Peter, et al.. (2009). Reasons for Non-use of Proven Interventions for Hospital Inpatients: Pharmacists’ Perspectives. The Canadian Journal of Hospital Pharmacy. 62(5). 381–5. 2 indexed citations
14.
Gorman, Sean K, Richard S Slavik, Jane de Lemos, et al.. (2009). Identifying Missed Opportunities to Curtail Antimicrobial Therapy for Presumed Ventilator-Associated Pneumonia Using the Clinical Pulmonary Infection Score. The Canadian Journal of Hospital Pharmacy. 62(3). 217–25. 1 indexed citations
15.
Slavik, Richard S, Sean K Gorman, Jane de Lemos, et al.. (2007). Dalteparin Versus Enoxaparin for Venous Thromboembolism Prophylaxis in Acute Spinal Cord Injury and Major Orthopedic Trauma Patients: ???DETECT??? Trial. The Journal of Trauma: Injury, Infection, and Critical Care. 62(5). 1075–1081. 37 indexed citations
16.
Lemos, Jane de, Denise Foster, & Dean R. Chittock. (2005). DOES USING A SEDATION SCALE REDUCE THE DURATION OF MECHANICAL VENTILATION IN THE CRITICALLY ILL: A PROSPECTIVE RANDOMIZED CONTROLLED TRIAL.. Critical Care Medicine. 33. A177–A177. 1 indexed citations
17.
Lemos, Jane de, Martin Tweeddale, & Dean R. Chittock. (2000). Measuring quality of sedation in adult mechanically ventilated critically ill patients. Journal of Clinical Epidemiology. 53(9). 908–919. 76 indexed citations
18.
Lemos, Jane de, et al.. (1999). Paralysis in the critically ill: Intermittent bolus pancuronium compared with continuous infusion. Critical Care Medicine. 27(12). 2648–2655. 21 indexed citations
19.
Lemos, Jane de, et al.. (1999). THE VANCOUVER INTERACTION AND CALMNESS SCALE. Critical Care Medicine. 27(Supplement). 166A–166A. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mary Beth Bobek Breakdown of academic impact, for papers by Chris Thorpe Breakdown of academic impact, for papers by Benjamin Hohlfelder Breakdown of academic impact, for papers by Mahmoud Ammar Breakdown of academic impact, for papers by Earnest Alexander Breakdown of academic impact, for papers by Sarah Welch Breakdown of academic impact, for papers by Allan Shustack Breakdown of academic impact, for papers by Codjo D. Djade Breakdown of academic impact, for papers by Maria C. Pruchnicki Breakdown of academic impact, for papers by P Mello
Rankless by CCL
2026